Corbus Pharmaceuticals logo

Corbus Pharmaceuticals

CRBP | NASDAQ
Chart Builder DCF Calculator
$3.38
-$0.01 (-0.29%)
At close: Nov 16, 2026, 4:00 PM ET
$3.19
-$0.19 (-5.62%)
After-hours: Nov 16, 2026, 7:39 PM ET
-0.29%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
26
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #902/1021 (Top 88%)

Key Statistics

Market Data

Market Cap $69.55M
1D Range
3.00 3.43
52W Range
2.86 12.15

Valuation (TTM)

PE -0.53
PB 0.82
EV/EBITDA 0.36

Valuation (NTM)

Forward PE N/A
Forward PEG 0.06
Price Target $34.00
Loading financial charts...

Profile

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibod...

Sector Healthcare
Industry Biotechnology
Employees 36
IPO Date Oct 27, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$34.00
Upside
+905.92%
Buy (7)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.